
Adults with asthma now have a new rescue medication to turn to after the U.S. Food and Drug Administration approved Airsupra on Wednesday. The drug is the first approved to combine albuterol (a beta-2 adrenergic agonist) and budesonide (a corticosteroid). It’s meant for the as-needed treatment or prevention of bronchoconstriction (narrowed airways) and to reduce… read on > read on >